Article
Successful sofosbuvir treatment with ribavirin dose reduction for chronic hepatitis C virus genotype 2 infection in a patient with ulcerative colitis: a case report.
BMC gastroenterology - 11 Jul 2016
Ohta Yuki, Kanda Tatsuo, Katsuno Tatsuro, Yasui Shin, Haga Yuki, Sasaki Reina, Nakamura Masato, Wu Shuang, Nakamoto Shingo, Arai Makoto, Yokosuka Osamu
Abstract excerpt
BACKGROUND: Ulcerative colitis is a lifelong, immunologically mediated disease. Direct-acting antivirals (DAAs) are now available for the treatment of chronic hepatitis C virus (HCV) infection. An interferon-free regimen appears useful, safe and effective for many patients for whom interferon-based treatment is contraindicated. CASE PRESENTATION: We studied a 56-year-old treatment-naïve Japanese man with chronic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.